In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Mind Medicine Inc (NASDAQ: MNMD) closed at $7.47 down -7.89% from its previous closing price of $8.11. In other words, the price has decreased by -$7.89 from its previous closing price. On the day, 1.03 million shares were traded. MNMD stock price reached its highest trading level at $7.58 during the session, while it also had its lowest trading level at $7.15.
Ratios:
For a deeper understanding of Mind Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 3.91. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on July 24, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On May 29, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $27.
On April 15, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $20.Leerink Partners initiated its Outperform rating on April 15, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 25 ’24 when Sullivan Mark sold 17,854 shares for $7.22 per share. The transaction valued at 128,906 led to the insider holds 182,146 shares of the business.
Barrow Robert sold 15,659 shares of MNMD for $113,058 on Jun 25 ’24. The Chief Executive Officer now owns 564,543 shares after completing the transaction at $7.22 per share. On Jun 25 ’24, another insider, Karlin Dan, who serves as the Chief Medical Officer of the company, sold 6,925 shares for $7.22 each. As a result, the insider received 49,998 and left with 351,527 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 536886784 and an Enterprise Value of 298744992.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -5.75%, while the 200-Day Moving Average is calculated to be 19.58%.
Shares Statistics:
For the past three months, MNMD has traded an average of 1.39M shares per day and 897600 over the past ten days. A total of 41.10M shares are outstanding, with a floating share count of 27.16M. Insiders hold about 3.54% of the company’s shares, while institutions hold 121.13% stake in the company. Shares short for MNMD as of 1721001600 were 9244756 with a Short Ratio of 6.67, compared to 1718323200 on 6744850. Therefore, it implies a Short% of Shares Outstanding of 9244756 and a Short% of Float of 12.870000000000001.
